Related Experiment Video
Updated: Apr 11, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Sudden death in childhood cardiomyopathy: results from a long-term national population-based study
Tara Bharucha1, Katherine J Lee2, Piers E F Daubeney3
1University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Insights
Sudden cardiac death (SCD) risk varies in children with cardiomyopathy (CM). Phenotype, family history, and LV dysfunction severity are key predictors, highlighting the need for ongoing monitoring.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Genetics of Heart Disease
Background:
- Children with cardiomyopathy (CM) face a significant risk of sudden cardiac death (SCD).
- The precise incidence and contributing risk factors for SCD in pediatric CM remain incompletely understood.
- Understanding these factors is crucial for risk stratification and management.
Purpose of the Study:
- To determine the incidence of SCD in children with various cardiomyopathy phenotypes.
- To identify specific risk factors associated with SCD across different CM types.
- To leverage data from a long-term population-based study of childhood CM.
Main Methods:
- Utilized data from the National Australian Childhood Cardiomyopathy Study (NACCS), a longitudinal cohort.
- Included children diagnosed with primary CM between 1987 and 1996, under 10 years of age.
- Employed survival analysis to explore cumulative incidence and risk factors for SCD.
Main Results:
- Out of 289 patients, 16 (5.5%) experienced SCD over a median follow-up of 11.9 years.
- SCD risk significantly varied by CM phenotype (p=0.007).
- Cumulative 15-year SCD incidence: 5% (DCM), 6% (HCM), 12% (restrictive CM), 23% (LV noncompaction). Risk factors included age, family history, LV dysfunction (DCM), and posterior wall thickness Z-score (HCM).
Conclusions:
- Cardiomyopathy phenotype, family history, LV systolic dysfunction severity, and LV hypertrophy extent are key predictors of SCD.
- The identified risk factors provide targets for early intervention and risk stratification.
- Continued follow-up into adulthood is essential, as SCD risk may persist.
Background:
Children with cardiomyopathy (CM) are at risk of sudden cardiac death (SCD), but the incidence and risk factors for this outcome are not clear.
Objectives:
This study sought to determine the incidence and risk factors for SCD in children with varying CM phenotypes from a long-term population-based study of childhood CM.
Methods:
The NACCS (National Australian Childhood Cardiomyopathy Study) is an ongoing longitudinal cohort study including all children in Australia with primary CM who were diagnosed between January 1, 1987, and December 31, 1996, and were <10 years of age. The cumulative incidence and risk factors for SCD within individual CM phenotypes were explored using survival analysis.
Results:
Of 289 eligible patients, 16 (5.5%) experienced SCD over a median follow-up of 11.9 years (interquartile range: 1.7 to 15.4). The risk of SCD varied according to CM phenotype (p=0.007). The cumulative incidence of SCD at 15 years was 5% for dilated cardiomyopathy (DCM), 6% for hypertrophic cardiomyopathy (HCM), 12% for restrictive cardiomyopathy, and 23% for left ventricular (LV) noncompaction. Older age at diagnosis, positive family history of CM, and severity of LV dysfunction were related to increased risk of SCD in patients with DCM, and a higher posterior wall thickness Z-score was the sole risk factor identified for patients with HCM.
Conclusions:
Predictors of SCD include CM phenotype, family history of CM (DCM), severity of systolic dysfunction (DCM), and extent of LV hypertrophy (HCM). Continuing follow-up of this cohort into adulthood is likely to reveal an ongoing risk of SCD.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy IV: Restrictive Cardiomyopathy

